dc.contributor.author | Uzel, O. E. | |
dc.contributor.author | Pak, Y. | |
dc.contributor.author | Abacioglu, U. | |
dc.contributor.author | Altun, M. | |
dc.contributor.author | Kaplan, B. | |
dc.contributor.author | Dalmaz, G. | |
dc.contributor.author | Esassolak, M. | |
dc.contributor.author | Yavuz, A. A. | |
dc.contributor.author | Ozyar, E. | |
dc.date.accessioned | 2021-03-02T23:22:54Z | |
dc.date.available | 2021-03-02T23:22:54Z | |
dc.identifier.citation | Uzel O. E. , Ozyar E., Pak Y., Abacioglu U., Altun M., Kaplan B., Dalmaz G., Esassolak M., Yavuz A. A. , "The Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study", 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_121b1701-5b28-450d-b94c-353eab276ba6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/17640 | |
dc.identifier.uri | https://doi.org/10.1016/j.ijrobp.2009.07.894 | |
dc.language.iso | eng | |
dc.subject | Nükleer Tıp | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.title | The Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 75 | |
dc.contributor.firstauthorID | 2505090 | |